The Trump administration is expected to announce deals with Eli Lilly and Novo Nordisk to cut prices of some weight loss ...

Empower your fitness and health journey using a mobile app. Check out a brief review of some of the most popular names (Lasta ...

Join the Fishfam as they make Madison's wish come true with Noom! Follow their health, weight loss, and fitness journey.

A new ‘microdosing’ trend lets pharmacies offer compounded versions of GLP-1 drugs even after the Food and Drug ...

The deal, with Eli Lilly and Novo Nordisk officials, is expected to lower the price of obesity drugs to $149 per month in ...

Together, the Diabetes Lifestyle Program and Glucose Forecasting tool advance Noom’s mission to make powerful health insights ...

The drugmaker said it would launch late-stage trials of the drug after participants lost as much as 20% of their body weight.

Research shows the battle to keep weight off isn’t about willpower—it’s biology. Here’s how scientists say we can work with ...

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

A deal with Lilly and Novo would be significant for the administration’s push for lower drug prices for Americans.

The Trump administration plans to announce a deal with pharmaceutical companies to sell discounted weight-loss drugs through ...

The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.